Global Diabetes Drugs Market 2011-2015

TechNavio's analysts forecast the Global Diabetes Drugs market to grow at a CAGR of 9.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in diabetic population. The Global Diabetes Drugs market has also been witnessing the trend of increasing awareness and education. However, the increasing use of complementary and alternative medicine (CAM) could pose a challenge to the growth of this market.

TechNavio's report, the Global Diabetes Drugs Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Global Diabetes Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors dominating this space include Eli Lilly and Co., Merck and Co. Inc., Novo Nordisk A/S and Sanofi S.A.

Key questions answered in this report:
What will the market size be in 2015 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.

TechNavio's research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.

01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Key Offerings
04. Market Landscape
04.1 Global Diabetes Drugs Market
Market Size
04.2 Available Drug Classes for Diabetes
04.3 Share of DPP4 Drugs in BRIC Countries in 2011
Brazil
India
Russia
China
Consolidated Share of DPP4 Drugs in BRIC Countries in 2011
04.4 Share of DPP4 Drugs in European Countries in 2011
France
Germany
Italy
Spain
UK
Consolidated Share of DPP4 Drugs in European Countries in 2011
04.5 Five Forces Analysis
05. Geographical Segmentation
06. Rate of Incidence and Prevalence
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Novo Nordisk A/S
Business Overview
SWOT Analysis
14.2 Merck and Co., Inc.
Business Overview
SWOT Analysis
14.3 Bristol-Myers Squibb Co.
Business Overview
SWOT Analysis
14.4 Sanofi S.A.
Business Overview
SWOT Analysis
15. Other Reports in this Series

List of Exhibits:
Exhibit 1: Global Diabetes Drugs Market 2011-2015 (US$ million)
Exhibit 2: Global Diabetes Drugs Market by Route of Administration
Exhibit 3: Global Diabetes Drugs Market by Geographical Segmentation 2011
Exhibit 4: Global Diabetes Drugs Market by Vendor Segmentation 2011